Kalb Michael Wayne
- SEC CIK
- 0001678248
No open-market purchases or sales filed in the past year.
Current role at each company
- CPRX Catalyst Pharmaceuticals, Inc.Chief Financial Officeras of Jul 17, 2026
- IMPL IPI Legacy Liquidation CoCFOas of May 12, 2023
- CINC CinCor Pharma, Inc.EVP & Chief Financial Officeras of Feb 24, 2023
- AMRN Amarin Corp PLCSVP and CFOas of Aug 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kalb Michael Wayne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMRN Amarin Corp PLC
SVP and CFO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 (view filing) | Aug 12 | 1 day | Kalb Michael WayneSVP and CFO | SSale | −120.0K | $5.25 | −$630.0K | −36.9%205.0K after |